Evaluation of betanin as a multi-target therapeutic agent against diabetic kidney disease, peripheral neuropathy, and dyslipidaemia in a rodent model of type 2 diabetes

Journal of Complementary and Integrative Medicine · Published 2026-07-24 · DOI 10.1515/jcim-2026-0132

Free full text

Authors (4)

Rathi Bishakha Jayprakash, Amrita Parida, Ramya Kateel, Jagnoor Singh Sandhu

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Jayprakash, R., Parida, A., Kateel, R., et al. (2026). Evaluation of betanin as a multi-target therapeutic agent against diabetic kidney disease, peripheral neuropathy, and dyslipidaemia in a rodent model of type 2 diabetes. Journal of Complementary and Integrative Medicine. https://doi.org/10.1515/jcim-2026-0132

Related articles